FDA's new guidelines on bulk drug compounding Pharmacy & Healthcare Legal Blog FDA Peptide Reclassification 2026: What Researchers Want Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA considers adding a dozen peptides to its bulk drug compounding list RAPS FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Unbans 14 Peptides for Legal US Compounding! : r Biohackers